# Using Plant-Derived Polysaccharides in the Management of Cognitive Disorders: Molecular and Clinical Perspectives

**Authors:** Yandong Li, Linlin Du, Mengyuan Wang, Xingyu He, Zongsuo Liang, Jingling Liu

PMC · DOI: 10.3390/nu18040555 · Nutrients · 2026-02-07

## TL;DR

This paper explores how plant-based polysaccharides may help treat cognitive disorders by targeting multiple mechanisms, including gut-brain interactions.

## Contribution

The study systematically reviews the therapeutic potential of plant-derived polysaccharides for cognitive disorders through various mechanisms.

## Key findings

- Plant polysaccharides show antioxidant, anti-inflammatory, and neuroprotective effects relevant to cognitive disorders.
- Modulation of the gut microbiota via polysaccharides may improve cognitive function through the gut–brain axis.
- Clinical evidence supports the potential of polysaccharides as safe and effective alternatives to current treatments.

## Abstract

Background: Cognitive disorders are a class of neurological diseases characterized by declines in cognitive function, imposing a heavy physical and mental burden on middle-aged and elderly individuals. Since the underlying mechanisms of cognitive disorders are not yet fully understood, and different types of cognitive disorders may involve distinct mechanisms, the development of drugs with multi-target therapeutic and preventive effects is of great significance. Currently approved drugs for Alzheimer’s disease, such as acetylcholinesterase inhibitors and NMDA receptor antagonists, show limited efficacy and poor prognosis, highlighting the urgent need for safe and effective alternative treatments. Methods: Plant-derived polysaccharides (PDPs) possess antioxidant, anti-inflammatory, neuroprotective, and immunomodulatory activities, and polysaccharides derived from traditional Chinese medicine, in particular, show great potential for treating cognitive disorders. In recent years, interventions with plant polysaccharides that modulate the gut microbiota to affect the “gut–brain axis” and improve cognitive function have become an emerging research focus. Clinical evidence has also increasingly supported the beneficial effects of polysaccharides on cognitive disorders. Therefore, this study focuses on plant polysaccharides in the intervention of cognitive disorder-related diseases, including both in vivo and in vitro experiments, and summarizes existing findings according to different mechanisms of action. Results and Conclusions: Relevant clinical reports are incorporated to provide a theoretical basis and strong support for the development of polysaccharide-based interventions and new drug development for cognitive disorders.

## Linked entities

- **Diseases:** Alzheimer’s disease (MONDO:0004975)

## Full-text entities

- **Genes:** PDP1 (pyruvate dehydrogenase phosphatase catalytic subunit 1) [NCBI Gene 54704] {aka PDH, PDP, PDPC, PDPC 1, PPM2A, PPM2C}, Bdnf (brain-derived neurotrophic factor) [NCBI Gene 24225], Casp3 (caspase 3) [NCBI Gene 25402] {aka CPP32-beta, Lice, Yama}, Bcl2 (BCL2, apoptosis regulator) [NCBI Gene 24224] {aka Bcl-2}, Bax (BCL2 associated X, apoptosis regulator) [NCBI Gene 24887], GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}, FFAR2 (free fatty acid receptor 2) [NCBI Gene 2867] {aka FFA2R, GPR43}, HDAC9 (histone deacetylase 9) [NCBI Gene 9734] {aka HD7, HD7b, HD9, HDAC, HDAC7B, HDAC9B}, NTF3 (neurotrophin 3) [NCBI Gene 4908] {aka HDNF, NGF-2, NGF2, NT-3, NT3}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Ephb1 (Eph receptor B1) [NCBI Gene 24338] {aka Ephb2, Erk, elk}, Akt1 (AKT serine/threonine kinase 1) [NCBI Gene 24185] {aka Akt}, Pik3cb (phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta) [NCBI Gene 85243], PYY (peptide YY) [NCBI Gene 5697] {aka PYY-I, PYY1}, FFAR3 (free fatty acid receptor 3) [NCBI Gene 2865] {aka FFA3R, GPR41}
- **Diseases:** synaptic damage (MESH:D012183), Cognitive impairment (MESH:D003072), LBPs (MESH:C564877), neurological disorders (MESH:D009461), post-stroke (MESH:D020521), dementias (MESH:D003704), amyloid (MESH:C000718787), learning and memory deficits (MESH:D007859), fatigue (MESH:D005221), depression (MESH:D003866), neurological diseases (MESH:D020271), obesity (MESH:D009765), cognitive or mood-related deficits (MESH:D019964), Neuronal (MESH:D009410), neuroinflammation (MESH:D000090862), impaired neurogenesis (MESH:D001750), ischemic injury (MESH:D017202), gastrointestinal disturbances (MESH:D005767), NAFLD (MESH:D065626), neurotoxic (MESH:D020258), neuropsychiatric disorders (MESH:D001523), MCI (MESH:D060825), AD (MESH:D000544), VaD (MESH:D015140), hallucinations (MESH:D006212), symptoms (MESH:D012816), Inflammatory (MESH:D007249), injury to (MESH:D014947), neurodegeneration (MESH:D019636)
- **Chemicals:** ROS (MESH:D017382), D-galactose (MESH:D005690), SCFA (MESH:D005232), beta-glucans (MESH:D047071), risperidone (MESH:D018967), indole (MESH:C030374), ethanol (MESH:D000431), serotonin (MESH:D012701), glucose (MESH:D005947), acetic acid (MESH:D019342), tryptophan (MESH:D014364), kynurenine (MESH:D007737), DP (MESH:D004176), oxiracetam (MESH:C040619), GABA (MESH:D005680), Acetate (MESH:D000085), arabinose (MESH:D001089), propionic acid (MESH:C029658), xylose (MESH:D014994), lipid (MESH:D008055), biopolymers (MESH:D001704), butyric acid (MESH:D020148), glutathione (MESH:D005978), water (MESH:D014867), carbohydrate (MESH:D002241), fatty acid (MESH:D005227), sertraline (MESH:D020280), monosaccharide (MESH:D009005), propionate (MESH:D011422), starch (MESH:D013213), galacturonic acid (MESH:C007819), MDA (MESH:D015104), Memantine (MESH:D008559), Polysaccharides (MESH:D011134), rhamnose (MESH:D012210), butyrate (MESH:D002087), maltodextrin (MESH:C008315), sugar (MESH:D000073893), unsaturated fatty acids (MESH:D005231), bile acid (MESH:D001647), mannose (MESH:D008358), valeric acid (MESH:C038780), Donepezil (MESH:D000077265), H2O2 (MESH:D006861), Dendrobium officinale polysaccharides (-)
- **Species:** Panax ginseng (Asiatic ginseng, species) [taxon 4054], Coprococcus eutactus (species) [taxon 33043], Abelmoschus esculentus (lady's fingers, species) [taxon 455045], Ganoderma lucidum (species) [taxon 5315], Paraprevotella (genus) [taxon 577309], Allium cepa (onion, species) [taxon 4679], Codonopsis pilosula (species) [taxon 86864], Roseburia (genus) [taxon 841], Opuntia ficus-indica (Indian-fig, species) [taxon 371859], Lycium barbarum (Duke of Argyll's teatree, species) [taxon 112863], Homo sapiens (human, species) [taxon 9606], Pyrus communis (pear, species) [taxon 23211], Faecalibacterium prausnitzii (species) [taxon 853], Astragalus membranaceus (species) [taxon 649199], Bifidobacterium (genus) [taxon 1678], Lactobacillus (genus) [taxon 1578], Rodentia (rodent, order) [taxon 9989], Polygonatum sibiricum (species) [taxon 261423], Ophiocordyceps sinensis (species) [taxon 72228], Mus musculus (house mouse, species) [taxon 10090], Bacteroides (genus) [taxon 816], Gynostemma pentaphyllum (jiaogulan, species) [taxon 182084], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Hippophae rhamnoides (sallowthorn, species) [taxon 193516], Prevotella (genus) [taxon 838], Dendrobium officinale (species) [taxon 142615], Rattus norvegicus (brown rat, species) [taxon 10116], Tremella fuciformis (snow fungus, species) [taxon 64657], Prunus persica (peach, species) [taxon 3760], Aloe vera (acibar, species) [taxon 34199], Saccharina japonica (species) [taxon 88149], Sinohyriopsis cumingii (species) [taxon 165450]
- **Cell lines:** PC12 — Rattus norvegicus (Rat), Rat adrenal gland pheochromocytoma, Cancer cell line (CVCL_0481)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942708/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942708/full.md

## References

90 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942708/full.md

---
Source: https://tomesphere.com/paper/PMC12942708